Genetics has a major role in early-onset dementia, but the correspondence between genotype and phenotype is largely tentative. We describe a 54-year-old with familial early-onset slowly-progressive episodic memory impairment with the P392L-variant in SQSTM1. The patient showed cortical atrophy and hypometabolism in the temporal lobes, but no amyloidosis biomarkers. As symptoms/neuroimaging were suggestive for Alzheimer's disease-but biomarkers were not-and considering the family-history, genetic analysis was performed, revealing the P392L-variant in SQSTM1, which encodes for sequestosome-1/p62. Increasing evidence suggests a p62 involvement in neurodegeneration and SQSTM1 mutations have been found to cause amyotrophic lateral sclerosis/frontotemporal dementia. Our report suggests that the clinical spectrum of SQSTM1 variants is wider.

Detection of the SQSTM1 Mutation in a Patient with Early-Onset Hippocampal Amnestic Syndrome / Carandini, T.; Sacchi, L.; Ghezzi, L.; Pietroboni, A. M.; Fenoglio, C.; Arighi, A.; Fumagalli, G. G.; De Riz, M. A.; Serpente, M.; Rotondo, E.; Scarpini, E.; Galimberti, D.. - In: JOURNAL OF ALZHEIMER'S DISEASE. - ISSN 1875-8908. - 79:2(2021), pp. 477-481. [10.3233/JAD-201231]

Detection of the SQSTM1 Mutation in a Patient with Early-Onset Hippocampal Amnestic Syndrome

Fumagalli G. G.;
2021-01-01

Abstract

Genetics has a major role in early-onset dementia, but the correspondence between genotype and phenotype is largely tentative. We describe a 54-year-old with familial early-onset slowly-progressive episodic memory impairment with the P392L-variant in SQSTM1. The patient showed cortical atrophy and hypometabolism in the temporal lobes, but no amyloidosis biomarkers. As symptoms/neuroimaging were suggestive for Alzheimer's disease-but biomarkers were not-and considering the family-history, genetic analysis was performed, revealing the P392L-variant in SQSTM1, which encodes for sequestosome-1/p62. Increasing evidence suggests a p62 involvement in neurodegeneration and SQSTM1 mutations have been found to cause amyotrophic lateral sclerosis/frontotemporal dementia. Our report suggests that the clinical spectrum of SQSTM1 variants is wider.
2021
2
Carandini, T.; Sacchi, L.; Ghezzi, L.; Pietroboni, A. M.; Fenoglio, C.; Arighi, A.; Fumagalli, G. G.; De Riz, M. A.; Serpente, M.; Rotondo, E.; Scarpini, E.; Galimberti, D.
Detection of the SQSTM1 Mutation in a Patient with Early-Onset Hippocampal Amnestic Syndrome / Carandini, T.; Sacchi, L.; Ghezzi, L.; Pietroboni, A. M.; Fenoglio, C.; Arighi, A.; Fumagalli, G. G.; De Riz, M. A.; Serpente, M.; Rotondo, E.; Scarpini, E.; Galimberti, D.. - In: JOURNAL OF ALZHEIMER'S DISEASE. - ISSN 1875-8908. - 79:2(2021), pp. 477-481. [10.3233/JAD-201231]
File in questo prodotto:
File Dimensione Formato  
2021 Carandini et al, JAD SQSTM1.pdf

Solo gestori archivio

Tipologia: Versione editoriale (Publisher’s layout)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 563.79 kB
Formato Adobe PDF
563.79 kB Adobe PDF   Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11572/355688
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 1
social impact